Laboratorios Farmaceuticos Rovi (LABFF) Short Interest Ratio & Short Volume C$65.86 0.00 (0.00%) (As of 12/24/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Laboratorios Farmaceuticos Rovi Short Interest DataLaboratorios Farmaceuticos Rovi (LABFF) has a short interest of 5,400 shares. This marks a 25.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1,300 shares to cover all short positions.Current Short Interest5,400 sharesPrevious Short Interest4,300 sharesChange Vs. Previous Month+25.58%Dollar Volume Sold Short$355,663.44Short Interest Ratio0.0 Days to CoverLast Record DateDecember 15, 2024Today's Trading Volume0 sharesAverage Trading Volume1,300 sharesToday's Volume Vs. Average0% Short Selling Laboratorios Farmaceuticos Rovi? Sign up to receive the latest short interest report for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLABFF Short Interest Over TimeLABFF Days to Cover Over TimeLABFF Percentage of Float Shorted Over Time Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Laboratorios Farmaceuticos Rovi Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20245,400 shares C$355,663.44 +25.6%N/A0 $65.86 11/30/20244,300 shares C$283,213.48 -23.2%N/A43 $65.86 11/15/20245,600 shares C$507,416.00 +3.7%N/A56 $90.61 10/31/20245,400 shares C$489,294.00 -6.9%N/A0 $90.61 10/15/20245,800 shares C$525,538.00 +100.0%N/A0 $90.61 9/30/20242,900 shares C$262,769.00 No ChangeN/A29 $90.61 Get the Latest News and Ratings for LABFF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE daily newsletter. 9/15/20242,900 shares C$262,769.00 +7.4%N/A0 $90.61 8/31/20242,700 shares C$244,647.00 +3.9%N/A27 $90.61 8/15/20242,600 shares C$235,586.00 No ChangeN/A0 $90.61 7/31/20242,600 shares C$235,586.00 +85.7%N/A0 $90.61 7/15/20241,400 shares C$126,854.00 -12.5%N/A14 $90.61 6/30/20241,600 shares C$137,680.00 +14.3%N/A0 $86.05 6/15/20241,400 shares C$120,470.00 +7.7%N/A0 $86.05 5/31/20241,300 shares C$111,865.00 +8.3%N/A0 $86.05 5/15/20241,200 shares C$103,260.00 +20.0%N/A0 $86.05 4/30/20241,000 shares C$86,050.00 -28.6%N/A0 $86.05 4/15/20241,400 shares C$120,470.00 +250.0%N/A0 $86.05 3/31/2024400 shares C$34,420.00 -55.6%N/A0 $86.05 3/15/2024900 shares C$77,445.00 -35.7%N/A9 $86.05 2/29/20241,400 shares C$72,800.00 -30.0%N/A14 $52.00 2/15/20242,000 shares C$104,000.00 -9.1%N/A0 $52.00 1/15/2024600 shares C$31,200.00 No ChangeN/A0 $52.00 12/31/2023600 shares C$31,200.00 -33.3%N/A0 $52.00 12/15/2023900 shares C$46,800.00 +80.0%N/A0 $52.00 11/30/2023500 shares C$26,000.00 No ChangeN/A0 $52.00 11/15/2023500 shares C$26,000.00 +66.7%N/A0 $52.00 10/31/2023300 shares C$15,600.00 No ChangeN/A0.8 $52.00 10/15/2023300 shares C$16,239.00 No ChangeN/A0 $54.13 9/30/2023300 shares C$16,239.00 -25.0%N/A0 $54.13 9/15/2023400 shares C$21,652.00 -97.0%N/A4 $54.13 8/31/202313,100 shares C$666,528.00 -42.5%N/A0 $50.88 8/15/202322,800 shares C$1.16 million No ChangeN/A0 $50.88 7/31/202322,800 shares C$1.16 million +192.3%N/A228 $50.88 7/15/20237,800 shares C$398,580.00 +2,500.0%N/A0 $51.10 6/30/2023300 shares C$15,330.00 No ChangeN/A0 $51.10 4/30/2023900 shares C$45,990.00 -74.3%N/A0 $51.10 4/15/20233,500 shares C$178,850.00 No ChangeN/A0 $51.10 3/31/20233,500 shares C$178,850.00 -5.4%N/A0 $51.10 3/15/20233,700 shares C$189,070.00 +184.6%N/A0 $51.10 2/28/20231,300 shares C$66,430.00 No ChangeN/A0 $51.10[PDF] The Opportunity in Gold (Ad)Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.Tap here to read it 1/31/2023300 shares C$15,330.00 -50.0%N/A0 $51.10 1/15/2023600 shares C$30,660.00 -25.0%N/A0 $51.10 12/30/2022800 shares C$40,880.00 No ChangeN/A0 $51.10 12/15/2022800 shares C$40,880.00 -90.1%N/A1.3 $51.10 11/30/20228,100 shares C$413,910.00 -3.6%N/A0 $51.10 11/15/20228,400 shares C$429,240.00 +13.5%N/A0 $51.10 10/31/20227,400 shares C$378,140.00 No ChangeN/A74 $51.10 10/15/20227,400 shares C$378,140.00 No ChangeN/A0 $51.10 9/30/20227,400 shares C$378,140.00 -2.6%N/A0 $51.10 9/15/20227,600 shares C$388,360.00 +2,433.3%N/A0 $51.10 8/31/2022300 shares C$0.00 No ChangeN/A3 $0.00 LABFF Short Interest - Frequently Asked Questions What is Laboratorios Farmaceuticos Rovi's current short interest? Short interest is the volume of Laboratorios Farmaceuticos Rovi shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 5,400 shares of LABFF short. Learn More on Laboratorios Farmaceuticos Rovi's current short interest. Is Laboratorios Farmaceuticos Rovi's short interest increasing or decreasing? Laboratorios Farmaceuticos Rovi saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 5,400 shares, an increase of 25.6% from the previous total of 4,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Laboratorios Farmaceuticos Rovi stock? Short selling LABFF is an investing strategy that aims to generate trading profit from Laboratorios Farmaceuticos Rovi as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Laboratorios Farmaceuticos Rovi? A short squeeze for Laboratorios Farmaceuticos Rovi occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LABFF, which in turn drives the price of the stock up even further. How often is Laboratorios Farmaceuticos Rovi's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LABFF, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Squeeze 3SBio Short Squeeze Agentix Short Squeeze Algernon Pharmaceuticals Short Squeeze Alpha Tau Medical Short Squeeze Anew Medical Short Squeeze Apollomics Short Squeeze Ascentage Pharma Group International Short Squeeze Ascletis Pharma Short Squeeze Avacta Group Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:LABFF) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Laboratorios Farmaceuticos Rovi, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Laboratorios Farmaceuticos Rovi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.